Progress in Pediatric Cardiology
Volume 23, Issue 1 , Pages 17-24 , September 2007

Pediatric cardiomyopathy: The Australian experience

  • Robert G. Weintraub

      Affiliations

    • Royal Children's Hospital, Melbourne, Australia
    • Corresponding Author InformationCorresponding author. Department of Cardiology, Royal Children's Hospital, Flemington Road, Parkville, VIC 3052, Australia. Tel.: +61 3 93455718; fax: +61 3 93456001.
    • Robert Gideon Weintraub is an Associate Professor in Pediatrics, University of Melbourne.
    • ,
  • Alan W. Nugent

      Affiliations

    • Texas Children's Hospital, Houston, United States
    • Alan William Nugent is an Assistant Professor Pediatrics, Baylor College of Medicine.
    • ,
  • Piers E.F. Daubeney

      Affiliations

    • Royal Brompton Hospital, London, United Kingdom
    • Piers Edward Francis Daubeney is a Consultant Paediatric and Fetal Cardiologist.

References 

  1. Boucek MM, Edwards LB, Keck BM, Trulock EP, Taylor DO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report—2005. J Heart Lung Transplant. 2005;24:968–982
  2. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002;287:1308–1320
  3. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349:1064–1075
  4. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med. 1989;320:749–755
  5. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93:841–842
  6. Aretz HT, Billingham ME, Edwards WD, et al. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3–14
  7. Sluysmans T, Colan SD. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol. 2005;99:445–457
  8. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol. 1992;19:619–629
  9. Nugent AW, Davis AM, Kleinert S, Wilkinson JL, Weintraub RG. Clinical, electrocardiographic, and histologic correlations in children with dilated cardiomyopathy. J Heart Lung Transplant. 2001;20:1152–1157
  10. Nugent AW, Daubeney PE, Chondros PC, et al. National Australian Childhood Cardiomyopathy S. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–1646
  11. Daubeney PE, Nugent AW, Chondros PC, et al. National Australian Childhood Cardiomyopathy S. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006;114:2671–2678
  12. Nugent AW, Daubeney PE, Chondros PC, et al. National Australian Childhood Cardiomyopathy S. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005;112:1332–1338
  13. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647–1655
  14. Strauss A, Lock JE. Pediatric cardiomyopathy—a long way to go. N Engl J Med. 2003;348:1703–1705
  15. Arola A, Jokinen E, Ruuskanen O, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol. 1997;146:385–933
  16. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation. 1994;90:1310–1318
  17. Akagi T, Benson LN, Lightfoot NE, Chin K, Wilson G, Freedom RM. Natural history of dilated cardiomyopathy in children. Am Heart J. 1991;121:1502–1506
  18. Friedman RA, Moak JP, Garson A. Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cardiol. 1991;18:152–156
  19. Tsirka AE, Trinkaus K, Chen SC, et al. Improved outcomes of pediatric dilated cardiomyopathy with utilization of heart transplantation. J Am Coll Cardiol. 2004;44:391–397
  20. Arola A, Tuominen J, Ruuskanen O, Jokinen E. Idiopathic dilated cardiomyopathy in children: prognostic indicators and outcome. Pediatrics. 1998;101:369–376
  21. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867–1876
  22. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation. 1999;99:1091–1100
  23. Grogan M, Redfield MM, Bailey KR, et al. Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1995;26:80–84
  24. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47:532–538
  25. Maron BJ, Tajik AJ, Ruttenberg HD, et al. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation. 1982;65:7–17
  26. Suda K, Kohl T, Kovalchin JP, Silverman NH. Echocardiographic predictors of poor outcome in infants with hypertrophic cardiomyopathy. Am J Cardiol. 1997;80:595–600

☆ Supported by grants from the Murdoch Children's Research Institute (Grant 98001), the National Heart Foundation of Australia (Grants G98M0159 and G05M2151), and the Australia and New Zealand Children's Heart Research Centre.

PII: S1058-9813(07)00007-0

doi: 10.1016/j.ppedcard.2007.05.006

Progress in Pediatric Cardiology
Volume 23, Issue 1 , Pages 17-24 , September 2007

Article Tools

* Image Usage & Resolution